Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
Low-Dose Prednisone for Inducing Remission in Rheumatoid Arthritis
September 26th 2019Jack Stacy, MSIV, of University of North Dakota, discusses a study he co-authored and presented at CCR West examining the use of low-dose prednisone to induce remission in patients with rheumatoid arthritis.
Read More
OPTN 2016 Revisions May Have Worsened Heart Transplant Mortality Rates
September 23rd 2019A study from cardiologists at UPMC Children's Hospital of Pittsburgh examining changes to criteria in 2016, which aimed to improve mortality rates among pediatric candidates for heart transplantation, found rates have worsened for certain conditions.
Read More
IVF, Assisted Reproduction Techiques Linked to Increased Gestational Diabetes
September 19th 2019A new meta-analysis presented at EASD 2019 found that women who gave birth following use of assisted reproductive techniques had a 53% increased risk of gestational diabetes compared to women who conceived naturally.
Read More
No PIIINP Reduction from Spironolactone in Heart Failure Prevention Study
September 17th 2019A proof of concept trial examining spironolactone for heart failure prevention presented at HFSA 2019 found spironolactone use did reduce PIIINP or that its impact on PIIINP was mitigated by galectin-3.
Read More
Dapagliflozin Fast Tracked for Reducing CV Death, Worsening Heart Failure
September 16th 2019Fast Track designation comes about a month after dapagliflozin received another Fast Track designation for delaying the progression of renal failure and prevent CV and renal death in patients with chronic kidney disease
Read More
Discussing Serious Illness Could Cut Costs, Improve End-of-Life Care
September 13th 2019A study from Brigham and Women's Hospital found asking clinicians if they would be surprised if older patients would die in the next month could save patients money on healthcare and improve quality of end-of-life care.
Read More
Leading Healthcare Organizations Urge Congress to Reform Prior Authorizations
September 12th 2019A group of 370 leading healthcare organizations have sent a letter to congress in support of a bipartisan bill that would protect Medicare Advantage Beneficiaries from delays caused by prior authorizations.
Read More